Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study.
A controlled trial of natalizumab for relapsing multiple sclerosis.
Tacrolimus potently inhibits human osteoclastogenesis induced by IL-17 from human monocytes alone and suppresses human Th17 differentiation.
Vision in a Phase 3 Trial of Natalizumab for Multiple Sclerosis: Relation to Disability and Quality of Life.
Ampyra (dalfampridine) medication guide
Correlates of Executive Functions in Multiple Sclerosis Based on Structural and Functional MR Imaging: Insights from a Multicenter Study.
Protective Associations of HDL with Blood Brain Barrier Injury in Multiple Sclerosis Patients.
Therapeutic effect of ghrelin in experimental autoimmune encephalomyelitis by inhibiting antigen-specific Th1/Th17 responses and inducing regulatory T cells.
Multiple sclerosis and oligodendroglioma: an exceptional association.
Predicting autoimmunity after alemtuzumab treatment of multiple sclerosis.
Evidence-based guideline: Assessment and management of psychiatric disorders in individuals with MS: Report of the Guideline Development Subcommittee of the American Academy of Neurology.
Associations between changes in ferritin levels and susceptibility-weighted imaging filtered phase in patients with relapsing-remitting multiple sclerosis over 24weeks of therapy with subcutaneous interferon beta-1a three times weekly.
Effects of exercise in experimental autoimmune encephalomyelitis (an animal model of multiple sclerosis).
Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study.
Randomized, open-label study to evaluate patient-reported outcomes with fingolimod after changing from prior disease-modifying therapy for relapsing multiple sclerosis: EPOC study rationale and design.
Association mapping of disease loci, by use of a pooled DNA genomic screen.
The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis.
Assessment of confirmed urinary tract infection in patients treated with dalfampridine for multiple sclerosis.
Psoriasis during natalizumab treatment for multiple sclerosis.
Comparative injection-site pain and tolerability of subcutaneous serum-free formulation of interferonβ-1a versus subcutaneous interferonβ-1b: results of the randomized, multicenter, Phase IIIb REFORMS study.
Dispositional optimism is unidimensional or bidimensional? The Portuguese revised Life Orientation Test.
Changes in phospholipid composition of the spinal cord in rabbits with allergic encephalomyelitis as an experimental model of multiple sclerosis.
Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials.
Sensitivity and specificity of SWI venography for detection of cerebral venous alterations in multiple sclerosis.
Current Immune Therapies of Autoimmune Disease of the Nervous System with Special Emphasis to Multiple Sclerosis.

Pages